Detalles de la búsqueda
1.
Reduced expression of annexin A2 is associated with impaired cell surface fibrinolysis and venous thromboembolism.
Blood
; 137(16): 2221-2230, 2021 04 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33512476
2.
VE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical Trial.
JAMA
; 329(16): 1356-1366, 2023 04 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37060545
3.
Avelumab in paediatric patients with refractory or relapsed solid tumours: dose-escalation results from an open-label, single-arm, phase 1/2 trial.
Cancer Immunol Immunother
; 71(10): 2485-2495, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35262780
4.
Long-term avelumab in advanced non-small-cell lung cancer: summaries and post hoc analyses from JAVELIN Solid Tumor.
Future Oncol
; 18(11): 1333-1342, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35144482
5.
Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study.
Lancet Oncol
; 19(11): 1468-1479, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30262187
6.
Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced melanoma (CheckMate 064): an open-label, randomised, phase 2 trial.
Lancet Oncol
; 17(7): 943-955, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-27269740
7.
Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia.
Blood
; 117(21): 5723-32, 2011 May 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-21389318
8.
Avelumab Dose Selection for Clinical Studies in Pediatric Patients with Solid Tumors.
Clin Pharmacokinet
; 61(7): 985-995, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35484319
9.
Pharmacometric modeling and machine learning analyses of prognostic and predictive factors in the JAVELIN Gastric 100 phase III trial of avelumab.
CPT Pharmacometrics Syst Pharmacol
; 11(3): 333-347, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34971492
10.
Real-world treatment patterns and outcomes in PD-L1-positive non-small cell lung cancer.
Immunotherapy
; 13(18): 1521-1533, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34346236
11.
Impact of subsequent immune checkpoint inhibitor treatment on overall survival with avelumab vs docetaxel in platinum-treated advanced NSCLC: Post hoc analyses from the phase 3 JAVELIN Lung 200 trial.
Lung Cancer
; 154: 92-98, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33636453
12.
Avelumab Versus Docetaxel in Patients With Platinum-Treated Advanced NSCLC: 2-Year Follow-Up From the JAVELIN Lung 200 Phase 3 Trial.
J Thorac Oncol
; 16(8): 1369-1378, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33845211
13.
Programmed Death-Ligand 1 Immunohistochemistry Assay Comparison Studies in NSCLC: Characterization of the 73-10 Assay.
J Thorac Oncol
; 15(8): 1306-1316, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32353599
14.
Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysis.
J Immunother Cancer
; 8(2)2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33037118
15.
Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis.
J Clin Oncol
; 35(2): 226-235, 2017 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28056206
16.
Stability of measurement of the immature platelet fraction.
Am J Hematol
; 85(8): 622-4, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20658593
17.
Ipilimumab administration for advanced melanoma in patients with pre-existing Hepatitis B or C infection: a multicenter, retrospective case series.
J Immunother Cancer
; 2(1): 33, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25317333
Resultados
1 -
17
de 17
1
Próxima >
>>